Capital Insight Partners, LLC Teva Pharmaceutical Industries LTD Transaction History
Capital Insight Partners, LLC
- $573 Million
- Q4 2024
A detailed history of Capital Insight Partners, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Capital Insight Partners, LLC holds 40,617 shares of TEVA stock, worth $669,368. This represents 0.16% of its overall portfolio holdings.
Number of Shares
40,617
Previous 14,000
190.12%
Holding current value
$669,368
Previous $252,000
255.16%
% of portfolio
0.16%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding TEVA
# of Institutions
677Shares Held
578MCall Options Held
25.5MPut Options Held
14.7M-
Black Rock Inc. New York, NY43MShares$708 Million0.02% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L339MShares$642 Million7.75% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.7MShares$604 Million48.01% of portfolio
-
Menora Mivtachim Holdings Ltd.28.4MShares$468 Million3.94% of portfolio
-
Exor Capital LLP London, X027.2MShares$448 Million17.5% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.3B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...